Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

Market Cap	7.82B
Revenue (ttm)	1.06B +49.8%
Net Income	231.61M +20.8%
EPS	3.57 +14.5%
Shares Out	72.79M
PE Ratio	30.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	334,771
Open	110.00
Previous Close	108.00
Day's Range	105.10 - 110.00
52-Week Range	69.18 - 163.18
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; egg freezing; embryo freezing; frozen embryo transfer; gynae co...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2009
• Employees: 120
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GAUDIUMIVF

Financial Performance

In fiscal year 2026, NSE:GAUDIUMIVF's revenue was 1.04 billion, an increase of 47.56% compared to the previous year's 707.24 million. Earnings were 244.61 million, an increase of 27.58%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Nov 12, 2026

Data Sources Report a data error